• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

感染在特发性肺纤维化急性加重中的作用。

The Role of Infection in Acute Exacerbation of Idiopathic Pulmonary Fibrosis.

机构信息

Department of Respiratory Medicine, Shanghai Pulmonary Hospital, Tongji University, School of Medicine, Shanghai, China.

School of Medicine, Suzhou University, Suzhou, China.

出版信息

Mediators Inflamm. 2019 Jan 3;2019:5160694. doi: 10.1155/2019/5160694. eCollection 2019.

DOI:10.1155/2019/5160694
PMID:30718973
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6335849/
Abstract

BACKGROUND

Acute exacerbation of IPF (AE-IPF) is associated with high mortality. We studied changes in pathogen involvement during AE-IPF and explored a possible role of infection in AE-IPF.

OBJECTIVES

Our purpose is to investigate the role of infection in AE-IPF.

METHODS

Overall, we recruited 170 IPF patients (48 AE-IPF, 122 stable) and 70 controls at Shanghai Pulmonary Hospital. Specific IgM against microbial pathogens and pathogens in sputum were assessed. RNA sequences of pathogens in nasopharyngeal swab of IPF patients were detected by PathChip. A panel of serum parameters reflecting immune function were assessed.

RESULTS

Antiviral/bacterial IgM was higher in IPF vs. controls and in AE-IPF vs. stable IPF. Thirty-eight different bacterial strains were detected in IPF patient sputum. Bacteria-positive results were found in 9/48 (18.8%) of AE-IPF and in 26/122 (21.3%) stable IPF. Fifty-seven different viruses were detected in nasopharyngeal swabs of IPF patients. Virus-positive nasopharyngeal swabs were found in 18/30 (60%) of tested AE-IPF and in 13/30 (43.3%) of stable IPF. AE-IPF showed increased inflammatory cytokines (IL-6, IFN-, MIG, IL-17, and IL-9) vs. stable IPF and controls. Mortality of AE-IPF in one year (39.5%) was higher compared to stable IPF (28.7%). IPF patients had different colonization with pathogens in sputum and nasopharyngeal swabs; they also displayed abnormally activated immune response, which was exacerbated during AE-IPF.

摘要

背景

特发性肺纤维化(IPF)急性加重(AE-IPF)与高死亡率相关。我们研究了 AE-IPF 期间病原体参与的变化,并探讨了感染在 AE-IPF 中的可能作用。

目的

我们旨在研究感染在 AE-IPF 中的作用。

方法

我们共招募了 170 名 IPF 患者(48 名 AE-IPF,122 名稳定)和 70 名对照于上海肺科医院。评估了针对微生物病原体和痰液中病原体的特异性 IgM。通过 PathChip 检测了 IPF 患者鼻咽拭子中病原体的 RNA 序列。评估了反映免疫功能的一系列血清参数。

结果

与对照组和稳定型 IPF 相比,IPF 患者的抗病毒/细菌 IgM 更高。在 IPF 患者的痰中检测到 38 种不同的细菌菌株。在 9/48(18.8%)例 AE-IPF 和 26/122(21.3%)例稳定型 IPF 中发现细菌阳性结果。在 IPF 患者的鼻咽拭子中检测到 57 种不同的病毒。在 18/30(60%)例测试的 AE-IPF 和 13/30(43.3%)例稳定型 IPF 中发现病毒阳性鼻咽拭子。AE-IPF 患者的炎症细胞因子(IL-6、IFN-γ、MIG、IL-17 和 IL-9)水平高于稳定型 IPF 和对照组。AE-IPF 在一年内的死亡率(39.5%)高于稳定型 IPF(28.7%)。AE-IPF 患者的痰液和鼻咽拭子中存在不同的病原体定植;他们还表现出异常激活的免疫反应,在 AE-IPF 期间加剧。

相似文献

1
The Role of Infection in Acute Exacerbation of Idiopathic Pulmonary Fibrosis.感染在特发性肺纤维化急性加重中的作用。
Mediators Inflamm. 2019 Jan 3;2019:5160694. doi: 10.1155/2019/5160694. eCollection 2019.
2
Prognostic value of IFN-γ, sCD163, CCL2 and CXCL10 involved in acute exacerbation of idiopathic pulmonary fibrosis.γ-干扰素、sCD163、CCL2 和 CXCL10 在特发性肺纤维化急性加重中的预后价值。
Int Immunopharmacol. 2019 May;70:208-215. doi: 10.1016/j.intimp.2019.02.039. Epub 2019 Mar 6.
3
Serum high-mobility group box 1 is associated with the onset and severity of acute exacerbation of idiopathic pulmonary fibrosis.血清高迁移率族蛋白 1 与特发性肺纤维化急性加重的发生和严重程度相关。
Respirology. 2020 Mar;25(3):275-280. doi: 10.1111/resp.13634. Epub 2019 Jul 3.
4
Infectious respiratory pathogens among patients with acute exacerbation of idiopathic pulmonary fibrosis during the coronavirus disease 2019 pandemic in Japan.在 2019 冠状病毒病大流行期间,日本特发性肺纤维化急性加重患者中的感染性呼吸道病原体。
Heart Lung. 2024 Sep-Oct;67:1-4. doi: 10.1016/j.hrtlng.2024.03.007. Epub 2024 Apr 2.
5
Long-term personal air pollution exposure and risk for acute exacerbation of idiopathic pulmonary fibrosis.长期个人空气污染暴露与特发性肺纤维化急性加重风险。
Environ Health. 2021 Aug 30;20(1):99. doi: 10.1186/s12940-021-00786-z.
6
Establishment of the mouse model of acute exacerbation of idiopathic pulmonary fibrosis.特发性肺纤维化急性加重小鼠模型的建立。
Exp Lung Res. 2016;42(2):75-86. doi: 10.3109/01902148.2016.1144835.
7
[Respiratory pathogen spectrum in pulmonary exacerbation of bronchiectasis in adults and its association with disease severity].[成人支气管扩张症肺部加重期的呼吸道病原体谱及其与疾病严重程度的关系]
Zhonghua Jie He He Hu Xi Za Zhi. 2019 Apr 12;42(4):254-261. doi: 10.3760/cma.j.issn.1001-0939.2019.04.002.
8
Effect of Acute Exacerbation of Idiopathic Pulmonary Fibrosis on Lung Transplantation Outcome.特发性肺纤维化急性加重对肺移植结局的影响。
Chest. 2018 Oct;154(4):818-826. doi: 10.1016/j.chest.2018.06.027. Epub 2018 Jun 30.
9
Associations of Serological Biomarkers of sICAM-1, IL-1, MIF, and su-PAR with 3-Month Mortality in Acute Exacerbation of Idiopathic Pulmonary Fibrosis.血清学生物标志物 sICAM-1、IL-1、MIF 和 su-PAR 与特发性肺纤维化急性加重期 3 个月死亡率的相关性。
Mediators Inflamm. 2020 Jul 6;2020:4534272. doi: 10.1155/2020/4534272. eCollection 2020.
10
Plasma microRNAs are associated with acute exacerbation in idiopathic pulmonary fibrosis.血浆微小RNA与特发性肺纤维化的急性加重相关。
Diagn Pathol. 2016 Nov 23;11(1):135. doi: 10.1186/s13000-016-0583-2.

引用本文的文献

1
Mechanisms and markers of lung ageing in health and disease.健康与疾病状态下肺衰老的机制与标志物
Eur Respir Rev. 2025 Jul 23;34(177). doi: 10.1183/16000617.0233-2024. Print 2025 Jul.
2
Predicting biomarkers of progressive pulmonary fibrosis: morphological, cytokine profile, and clinical portrait.预测进行性肺纤维化的生物标志物:形态学、细胞因子谱及临床特征
Front Immunol. 2025 Jun 19;16:1514439. doi: 10.3389/fimmu.2025.1514439. eCollection 2025.
3
Current advancements in the mechanisms and animal models of acute exacerbation of pulmonary fibrosis: a systematic review.

本文引用的文献

1
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.特发性肺纤维化诊断。美国胸科学会/欧洲呼吸学会/日本呼吸学会/拉丁美洲胸科学会临床实践指南。
Am J Respir Crit Care Med. 2018 Sep 1;198(5):e44-e68. doi: 10.1164/rccm.201807-1255ST.
2
Impaired diversity of the lung microbiome predicts progression of idiopathic pulmonary fibrosis.肺微生物组多样性受损可预测特发性肺纤维化的进展。
Respir Res. 2018 Feb 27;19(1):34. doi: 10.1186/s12931-018-0736-9.
3
Stimulator of Interferon Genes Deficiency in Acute Exacerbation of Idiopathic Pulmonary Fibrosis.
肺纤维化急性加重机制与动物模型的当前进展:一项系统综述
Front Pharmacol. 2025 May 30;16:1501085. doi: 10.3389/fphar.2025.1501085. eCollection 2025.
4
Comprehensive analyses of immune activity in COVID-19-vaccinated idiopathic pulmonary fibrosis patients.对接种新冠疫苗的特发性肺纤维化患者免疫活性的综合分析。
Front Immunol. 2025 Jan 8;15:1436491. doi: 10.3389/fimmu.2024.1436491. eCollection 2024.
5
The immune mechanisms of acute exacerbations of idiopathic pulmonary fibrosis.特发性肺纤维化急性加重的免疫机制
Front Immunol. 2024 Dec 16;15:1450688. doi: 10.3389/fimmu.2024.1450688. eCollection 2024.
6
Differences Between Patients with Probable UIP and Definite UIP on HRCT in Idiopathic Pulmonary Fibrosis: A Real-World Cohort Study.特发性肺纤维化中HRCT上可能的UIP和确诊的UIP患者之间的差异:一项真实世界队列研究
J Clin Med. 2024 Nov 26;13(23):7170. doi: 10.3390/jcm13237170.
7
Pharmacological targets and validation of remdesivir for the treatment of COVID-19-associated pulmonary fibrosis: A network-based pharmacology and bioinformatics study.瑞德西韦治疗 COVID-19 相关肺纤维化的药理学靶点及验证:基于网络的药理学和生物信息学研究。
Medicine (Baltimore). 2024 Sep 27;103(39):e39062. doi: 10.1097/MD.0000000000039062.
8
Acute exacerbation of idiopathic pulmonary fibrosis a narrative review primary focus on treatments.特发性肺纤维化急性加重:一项主要关注治疗的叙述性综述
J Thorac Dis. 2024 Jul 30;16(7):4727-4741. doi: 10.21037/jtd-23-1565. Epub 2024 Jul 11.
9
Rate of severe and fatal infections in a cohort of patients with interstitial lung disease associated with rheumatoid arthritis: a multicenter prospective study.类风湿关节炎相关间质性肺疾病患者队列中严重和致命感染的发生率:一项多中心前瞻性研究。
Front Immunol. 2024 Mar 28;15:1341321. doi: 10.3389/fimmu.2024.1341321. eCollection 2024.
10
The Role of Lung Microbiome in Fibrotic Interstitial Lung Disease-A Systematic Review.肺微生物组在肺纤维化性间质性肺疾病中的作用——系统综述。
Biomolecules. 2024 Feb 20;14(3):247. doi: 10.3390/biom14030247.
特发性肺纤维化急性加重期干扰素基因刺激因子缺乏症
Front Immunol. 2017 Dec 11;8:1756. doi: 10.3389/fimmu.2017.01756. eCollection 2017.
4
Microbes Are Associated with Host Innate Immune Response in Idiopathic Pulmonary Fibrosis.微生物与特发性肺纤维化中的宿主固有免疫反应相关。
Am J Respir Crit Care Med. 2017 Jul 15;196(2):208-219. doi: 10.1164/rccm.201607-1525OC.
5
Changes in the respiratory microbiome during acute exacerbations of idiopathic pulmonary fibrosis.特发性肺纤维化急性加重期呼吸微生物群的变化
Respir Res. 2017 Feb 1;18(1):29. doi: 10.1186/s12931-017-0511-3.
6
Host-Microbial Interactions in Idiopathic Pulmonary Fibrosis.特发性肺纤维化中的宿主-微生物相互作用
Am J Respir Crit Care Med. 2017 Jun 15;195(12):1640-1650. doi: 10.1164/rccm.201607-1408OC.
7
Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report.特发性肺纤维化急性加重:国际工作组报告。
Am J Respir Crit Care Med. 2016 Aug 1;194(3):265-75. doi: 10.1164/rccm.201604-0801CI.
8
Patients With Fibrotic Interstitial Lung Disease Hospitalized for Acute Respiratory Worsening: A Large Cohort Analysis.因急性呼吸功能恶化住院的纤维化间质性肺疾病患者:一项大型队列分析。
Chest. 2016 May;149(5):1205-14. doi: 10.1016/j.chest.2015.12.026. Epub 2016 Jan 11.
9
Acute exacerbation of idiopathic pulmonary fibrosis: shifting the paradigm.特发性肺纤维化急性加重:范式转变。
Eur Respir J. 2015 Aug;46(2):512-20. doi: 10.1183/13993003.00419-2015.
10
Acute exacerbations complicating interstitial lung disease.间质性肺疾病并发的急性加重
Curr Opin Pulm Med. 2014 Sep;20(5):436-41. doi: 10.1097/MCP.0000000000000073.